Therox Inc.
This article was originally published in Start Up
Executive Summary
Devices for the hospital market. TherOx has a technology which aims to concentrate a large amount of oxygen into a small amount of fluid, and locally deliver that fluid, without bubbles or damage to blood cells or tissue. The device uses saline and oxygen supplied by the hospital, a guidewire familiar to cardiologists, a proprietary perfusion catheter and a small, bed-side oxygen concentrator.
You may also be interested in...
Changing Minds at the FDA
Visioncare's recent success in getting an FDA advisory panel to change a recommendation is a rare and noteworthy achievement. But the agency could prove to be an even more formidable barrier - and a potential catalyst for change - for the device sector going forward.
At TCT, TherOx Scores Big in a Clinical Trials Climate That Isn't Always Sunny
At this year's TCT conference, TherOx scored big in a clinical trials climate that isn't always sunny and which hasn't always produced positive clinical trials' results.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.